Aptilon (APZ) Announces the Signing of an Important Enterprise Commitment with Merck & Co., Inc. (MRK)
7/3/2007 10:35:34 AM
MONTREAL, July 3 /CNW Telbec/ - Aptilon Corporation (TSX.V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel today announced that Merck & Co., Inc. has renewed its relationship with Aptilon's AxcelRx(SM) Live. Merck uses the company's video detailing software platform and hopes to increase the number of potential physician users who are interested in participating via Aptilon's ReachNet physician access network. Merck has renewed its agreement for a term of one-year for an undisclosed amount. The revenues generated from this agreement are two-fold, including both fixed fees to license, manage and support the platform as well as performance fees that will vary based upon usage.
comments powered by